Chiral 3-(4,5-dihydrooxazol-2-yl)phenyl alkylcarbamates as novel FAAH inhibitors: Insight into FAAH enantioselectivity by molecular docking and interaction fields.
Myllymaki MJ, Kasnanen H, Kataja AO, Lahtela-Kakkonen M, Saario SM, Poso A, Koskinen AM, Eur J Med Chem, 2009 Oct - link